Edwards Lifesciences (EW) Finished Goods (2010 - 2026)

Edwards Lifesciences' Finished Goods history runs 13 years deep, the most recent figure standing at $674.4 million for Q1 2026.

• On a quarterly basis, Finished Goods rose 13.44% year-over-year to $674.4 million in Q1 2026; TTM through Mar 2026 was $674.4 million, a 13.44% increase from a year earlier, with the FY2025 full-year figure at $676.7 million, up 11.04% from the prior year.
• Finished Goods was little changed at $674.4 million in Q1 2026 per EW's latest filing, from $676.7 million in the prior quarter.
• Across five years, Finished Goods topped out at $676.7 million in Q4 2025 and bottomed at $511.4 million in Q4 2023.
• The 4-year median for Finished Goods is $620.8 million (2024), against an average of $617.2 million.
• Across the five-year window, Finished Goods advanced 19.16% in 2024 and decreased 11.1% in 2025, its largest moves.
• Year by year, Finished Goods stood at $511.4 million in 2023, then grew by 19.16% to $609.4 million in 2024, then gained by 11.04% to $676.7 million in 2025, then dropped by 0.34% to $674.4 million in 2026.
• Per Business Quant, the three latest EW Finished Goods figures stand at $674.4 million (Q1 2026), $676.7 million (Q4 2025), and $642.2 million (Q3 2025).